MARATTO

letter · Psychiatry and Clinical Neurosciences

Is clozapine use a risk of hematological malignancies? Insights from a meta‐analysis “Clozapine and Malignancy Risk”

20252 citationsAlexandria University

Abstract

Data S1. Supporting Information. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Research topics

  • Schizophrenia research and treatment
  • Electroconvulsive Therapy Studies
  • Parkinson's Disease and Spinal Disorders

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1111/pcn.13827

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.